← Back to Search

Intraperitoneal and Extraperitoneal Uterosacral Ligament Suspensions for Post-Hysterectomy Vaginal Vault Prolapse

N/A
Waitlist Available
Led By Tristi Muir, MD
Research Sponsored by The Methodist Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 month
Awards & highlights
No Placebo-Only Group

Summary

This trial is comparing two different approaches to surgery for a vaginal prolapse that can occur after a hysterectomy.

Eligible Conditions
  • Vaginal vault prolapse
  • Vaginal Prolapse
  • Vaginal Vault Prolapse

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Operative time (minutes)
Secondary study objectives
Estimated blood loss (ml)
Frequency of perioperative complications (%)
Hospital length of stay (hours)
+13 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Intraperitoneal GroupActive Control1 Intervention
Vaginal intraperitoneal uterosacral ligament suspension group
Group II: Extraperitoneal GroupActive Control1 Intervention
Vaginal extraperitoneal uterosacral ligament suspension group

Find a Location

Who is running the clinical trial?

The Methodist Hospital Research InstituteLead Sponsor
287 Previous Clinical Trials
81,746 Total Patients Enrolled
Tristi Muir, MDPrincipal InvestigatorThe Methodist Hospital Research Institute
Danny Mounir, MDPrincipal Investigator - The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
~6 spots leftby Dec 2025